2016
DOI: 10.1021/acs.analchem.6b04251
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Chemical Sensors: Role of Biocompatibility on Performance and Utility

Abstract: Graphical Abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
60
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 68 publications
(60 citation statements)
references
References 268 publications
(741 reference statements)
0
60
0
Order By: Relevance
“…One strategy to inhibit the foreign body reaction is to release anti‐inflammatory drugs in the vicinity of a biosensor. Drug‐releasing polymer layers or microfluidic systems can be integrated into microfabricated probes (Figure ) and biosensors coated with a porous polymer membrane containing anti‐inflammatory pharmaceutical agents have been proposed . Nitric oxide (NO) is a molecule that blocks platelet aggregation and hemostasis, and it also displays anti‐inflammatory and pro‐angiogenic properties that make it a prime candidate for being incorporated into in vivo biosensors to improve biocompatibility .…”
Section: Biocompatibilitymentioning
confidence: 99%
See 1 more Smart Citation
“…One strategy to inhibit the foreign body reaction is to release anti‐inflammatory drugs in the vicinity of a biosensor. Drug‐releasing polymer layers or microfluidic systems can be integrated into microfabricated probes (Figure ) and biosensors coated with a porous polymer membrane containing anti‐inflammatory pharmaceutical agents have been proposed . Nitric oxide (NO) is a molecule that blocks platelet aggregation and hemostasis, and it also displays anti‐inflammatory and pro‐angiogenic properties that make it a prime candidate for being incorporated into in vivo biosensors to improve biocompatibility .…”
Section: Biocompatibilitymentioning
confidence: 99%
“…Drug‐releasing polymer layers or microfluidic systems can be integrated into microfabricated probes (Figure ) and biosensors coated with a porous polymer membrane containing anti‐inflammatory pharmaceutical agents have been proposed . Nitric oxide (NO) is a molecule that blocks platelet aggregation and hemostasis, and it also displays anti‐inflammatory and pro‐angiogenic properties that make it a prime candidate for being incorporated into in vivo biosensors to improve biocompatibility . Dexamethasone has also been incorporated into hydrogel membranes by using microspheres or carbon nanotubes , and its slow release into the local microenvironment has been shown to block scar formation.…”
Section: Biocompatibilitymentioning
confidence: 99%
“…[ 30,32 ] Owing to this short half‐life, the sphere of influence of NO is limited around its origin; using Fick's second law of diffusion, its diffusion distance at half‐life is 5–490 µm. [ 33 ] Due to this extremely short physiological half‐life in vivo and localized concentration, only techniques such as fluorescence imaging, [ 34 ] electron paramagnetic resonance (EPR) spectroscopy, [ 35 ] and electrochemical sensors [ 30,36 ] have been able to provide some answers. For example, EPR measurements in vivo on the brains of rabies‐infected rats have determined NO concentrations of 1 × 10 −6 m or less in healthy rats, which increased to ≈12 × 10 −6 m at day 5 postinfection (onset of the disease) and to ≈30 × 10 −6 m at day 7.…”
Section: Introductionmentioning
confidence: 99%
“…These challenges may partially or completely hinder the function of implanted sensors, including accuracy and service life. [ 313,314 ]…”
Section: Applications Of Anti‐fbr Materialsmentioning
confidence: 99%